Horizon Technology Finance is a business development company (BDC) that provides secured venture debt to technology, life science, and sustainability companies. Its Q3 2026 report arrives at a pivotal moment, roughly six months after the company completed its merger with Monroe Capital Corporation in April 2026. That transaction infused roughly $141.1 million in cash and expanded the capital base, positioning Horizon to pursue larger lending opportunities. The previous quarter's NII was depressed by one-time merger costs, so this report offers a cleaner look at the company's underlying earning power. For income-focused investors, the key question is whether NII comfortably covers the regular distribution while the newly combined platform begins to deploy capital. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Because Horizon is a BDC, investors and analysts typically emphasize NII per share and NAV per share rather than conventional revenue and earnings per share figures. In Q2 2026, NII was $7.4 million, or $0.11 per share, down from $0.28 per share a year earlier, largely because of $4.4 million in non-recurring merger expenses. That quarterly payout of $0.11 fell short of the $0.18 regular distribution, underscoring why distribution coverage will be a focal point this quarter.
Heading into Q3 2026, investors will watch whether NII rebounds now that one-time costs have rolled off. Prior NII figures provide useful context: $0.32 per share in Q3 2025, $0.18 in Q4 2025, and $0.19 in Q1 2026. Other metrics in focus include the debt portfolio yield (14.9% in Q2 2026), the committed backlog, and whether NAV per share remains stable at around $6.98. Prepayment activity and credit quality across the venture-debt book are also expected to influence results.
Sentiment heading into the Q3 2026 report centers on whether Horizon can demonstrate that the Monroe Capital merger is translating into durable portfolio and earnings growth. The stock's recent trajectory has reflected both the income appeal of a monthly distribution and lingering questions about distribution coverage and NAV stability. Investors will be watching for commentary on origination volume, the $180 million committed backlog reported at the end of Q1 2026, and any change in credit trends. A rebound in NII per share toward or above the regular $0.18 quarterly distribution, combined with steady NAV, would likely be viewed favorably, while continued coverage shortfalls or rising credit stress could weigh on sentiment. From what I see, this is important because it ties directly to long-term income sustainability for shareholders.
Beyond the headline NII figure, investors should monitor several factors that will shape Horizon's trajectory in the coming quarters. First is distribution sustainability. Management has set a regular monthly payout of $0.06 per share and has previously supplemented it with special distributions tied to undistributed "spillover" income. Whether NII can cover these payouts on a sustained basis is a central question for income investors.
Second is portfolio deployment. With the merger providing additional capital and an expanded relationship with Monroe Capital, the pace of new originations and the size of the committed backlog will indicate how quickly the combined platform is gaining traction.
Finally, credit quality and interest rates remain important. Venture-debt borrowers are sensitive to funding costs and liquidity conditions, so investors should watch the internal credit ratings of the portfolio, any realized losses, and how the company's predominantly floating-rate loan book responds to changes in benchmark rates. These factors, taken together, will offer a clearer picture of whether the post-merger strategy is building sustainable long-term value. I'm watching this closely as it could influence positioning in the specialty finance space.
In my day-to-day analysis, I find Tickeron’s AI Screener helpful for quickly filtering BDC and specialty finance names by fundamentals, technical patterns, and AI signals. It lets me compare metrics like yield and NAV stability across peers without spending hours on manual screens, which adds useful context when preparing for reports like this one from Horizon Technology Finance (HRZN).
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
HRZN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 26 of 47 cases where HRZN's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 55%.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +2.12% 3-day Advance, the price is estimated to grow further. Considering data from situations where HRZN advanced for three days, in 156 of 316 cases, the price rose further within the following month. The odds of a continued upward trend are 49%.
The Momentum Indicator moved below the 0 level on October 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HRZN as a result. In 47 of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 63%.
HRZN moved below its 50-day moving average on October 05, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for HRZN crossed bearishly below the 50-day moving average on October 05, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 47%.
The 50-day moving average for HRZN moved below the 200-day moving average on October 23, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HRZN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 59%.
The Aroon Indicator for HRZN entered a downward trend on October 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 59 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating fairly steady price growth. HRZN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 75 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.633) is normal, around the industry mean (2.383). P/E Ratio (10.649) is within average values for comparable stocks, (-2.559). Projected Growth (PEG Ratio) (1.907) is also within normal values, averaging (1.319). Dividend Yield (0.091) settles around the average of (0.272) among similar stocks. P/S Ratio (11.062) is also within normal values, averaging (15.798).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HRZN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a closed-end investment trust
Industry InvestmentManagers